Our understanding of the human T1D etiology along with proposed therapeutic options has greatly advanced during the last decades. Nevertheless, the rate of bench to bedside translation is still disappointingly slow. During the discussion, our panelists explored key topics on: Major discoveries and knowledge gaps in our understanding of T1D pathogenesis. Emerging therapies to treat or prevent T1D, and their potential challenges.